Upcoming Medical Conferences in Sweden

26th EASM – The European Sport Management Conference is organized by European Association for Sport Management (EASM) and will be held during Sep 05 - 08, 2018 at Clarion Hotel & Congress Malmö Live, Malmo, Skane, Sweden. Course Description: The conference theme aims to reflect ongoing processes of change and challenges within sport and society to be handled by sport organizations/actors at different levels. • It is a highly relevant theme both from a sport and societal perspective. • It has a clear connection to both the Malmö and international context. • It facilitates excellent opportunities for cooperation between different sectors. • It creates an opportunity to challenge and develop the dominant traditions within sports management. Also, the conference includes the regular topics and workshops of the European Sport Management Conference. Additional details will be posted as soon as they are available.

Basic Neuroscience of Movement Disorders is organized by International Parkinson and Movement Disorder Society (MDS) and will be held from Sep 14 - 15, 2018 at Karolinska Institute, Stockholm, Sweden. The target audience for this medical event is intended for neurologists, geriatricians, and basic scientists interested in movement disorders. Course Description: The overall aim of this course is to teach young research-oriented neurologists and neuroscientists about fundamental mechanisms underlying movement disorders. The course participants will learn about clinical and genetic characteristics, preclinical models and pathophysiological foundations of movement disorders and their therapies. An important goal is to update clinical neurologists and neuroscientists on the forefront and the latest developments in research of movement disorders. The course will hopefully engage young neurologists and neuroscientists into research on movement disorders and to promote translational research involving multidisciplinary approaches. The course mainly consists of lectures by international experts on Parkinson's disease and movement disorders. Local experts will serve as chairs to facilitate discussion after each lecture. They will also organize questioning from the participants and ensure that the time schedule is followed properly. There will also be panel discussions with experts. During breaks and the course dinner, the participants will also get the opportunity to interact with faculty and peers. Course Objectives: • Recognize recent basic science developments in genetics and imaging in Parkinson’s disease and their clinical implications • Review recent basic science developments using cellular and animal models of parkinsonism and their potential to translate into the clinical situation • Summarize recent basic science developments in dystonia, Huntington’s disease, and ataxias • Analyze interactions between basic neuroscientists and movement disorders specialists • Compare novel approaches aimed at treating movement disorders • Identify important clinical aspects of movement disorders where more basic research is needed Additional details will be posted as soon as they are available.

Practical Management of Impurities and Development of Effective and Comprehensive Control Strategies is organized by Scientific Update Ltd and will be held from Sep 19 - 20, 2018 at Elite Palace Hotel, Stockholm, Sweden. The target audience for this medical event is Scientists, managers and team leaders involved in the development of pharmaceuticals and Engineers. This course is particularly relevant to process development chemists and analysts at all levels, but will also be of interest to late stage medicinal chemists who want to gain a greater understanding of the impact of impurities. Course Outline: This 2 day course is aimed at providing a holistic understanding of the challenges and issues associated with implementing an effective control strategy for all impurity types. It will examine key areas, specifically, impurity qualification, mutagenic impurities, elemental impurities, extractives and leachables and solvents. In each case it will examine practical approaches through both case studies and practical exercises and in all instances provide clarity as to the current and emerging regulatory frameworks Benefits to Attending: What will attendees gain from the course? • What are the key impurity classes and how they relate to the overall manufacturing process. • A clear understanding of the pivotal role played by chemists and analysts in the impurity management process. • How to effectively relate product quality to impurity qualification ensuring that qualification studies properly align to process capability. • How to align impurity management to the over process control strategy – to optimise effective control. • How to use effective impurity management to drive key process and regulatory decisions e.g. starting material definition and defence. Price: Course Fee: EUR 1700 Speakers: Dr Andrew Teasdale Additional details will be posted as soon as they are available.

14th Biennial Congress of the European Association of Oral Medicine (EAOM) in conjunction with the World Workshop on Oral Medicine VII is organized by European Association of Oral Medicine (EAOM) and will be held from Sep 27 - 29, 2018 at Lindholmen Science Park, Gothenburg, Vastra Gotaland County, Sweden. Additional details will be posted as soon as they are available.

Adult Extracorporeal Membrane Oxygenation (ECMO) for respiratory failure and septic shock is organized by Extracorporeal Life Support Organization and will be held from Oct 01 - 04, 2018 at Karolinska University Hospital, Stockholm, Sweden. The target audience for this medical event is for physicians (intensivists, surgeons etc), nurses, perfusionists and other health care professionals Course Description: This Conference includes simulations of ECMO patients, practical training in managing the ECMO circuit with a change of different components etc, computer simulations of physiology and didactic lectures. Simulations and practical training will be performed in small groups of 6 participants together with one or two instructors. The lectures will cover subjects like components of the ECMO circuit, indications for ECMO, contraindications, managing the patient on ECMO, cannulation strategy, physiology, anticoagulation, troubleshooting etc. Additional details will be posted as soon as they are available.

13th European Association of Neuro-Oncology (EANO) meeting is organized by European Association of Neuro-Oncology (EANO) and would be held during Oct 11 - 14, 2018 at Stockholm, Sweden. Additional details will be posted as soon as they are available.

13th European Nitrogen Fixation Conference (ENFC) is organized by Conference Organisation, Association Development & Project Management (CAP) Partner and will be held from Aug 18 - 21, 2018 at Munchenbryggeriet, Stockholm, Sweden. This European based biennial congress brings together scientists focused on biological N2 fixation (BNF) from diverse research topics of biochemistry, microbiology, computational genomics, plant physiology, and more recently genetic engineering and aquatic microbiology. The first ENFC was held in Szeged, Hungary, in 1994, with an emphasis on participation by young researchers. The most recent ENFC in 2016 was a clear demonstration of 'research without borders' as 294 participants, 30 % of which came from outside of the European Union (EU), including 8 % from developing countries, attended the 12th ENFC in Budapest, Hungary. A large percent (29%) of the participants were PhD students. The value of the ENFC series has been proven over the years. Although a smaller congress by today's standards, it has drawn the participation and presentation by leading experts of BNF. The program combines classical topics within the BNF field (e.g. biochemistry, evolution, signal transduction, N2 fixing symbioses) with highly relevant and timely topics for modern society (e.g. climate change, present and future use of BNF in agriculture). Satellite meetings and symposia, such as the Genomics of Nitrogen-Fixing Organisms and a Symposia on Aquatic N2 fixation, will provide extra benefits for ENFC participants. The end result of the ENFC is the attraction of a diverse group of participants. Furthermore, support enabling the participation of young researchers will be provided as per tradition. The ENFC will provide unique opportunities and specialized sessions to share and discuss latest scientific achievements in BNF and the molecular interaction between plants and symbiotic microorganisms. Join us to meet the researchers who will present their hot research topics and key institutions. Speakers: Ray Dixon, Christopher Voigt, Dennis Dean, John C. Meeks, Lance Seefeldt, Makoto Hayashi, Marie-Charlotte Nilsson Hegethorn, Martin Parniske, Myriam Charpentier Additional details will be posted as soon as they are available.

2nd Epidemiology Group Conference is organized by International Society for Influenza and other Respiratory Virus Diseases (ISIRV) and would be held during Nov 08 - 09, 2018 at Stockholm, Sweden. Additional details will be posted as soon as they are available.

AOTrauma Masters Course - Foot & Ankle Reconstruction is organized by AOTrauma and Will be held on Nov 11, 2018 at Stockholm, Sweden. Additional details will be posted as soon as they are available.

Proteomics and its Application to Translational and Precision Medicine (D3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Apr 07 - 11, 2019 at Clarion Hotel Sign, Stockholm, Sweden. Course Description : Proteomics methods have advanced tremendously in just the last few years. Apart from increasingly powerful mass-spectrometric methods, global antibody based methods, chemical biology approaches and genetics/genomics approaches and their combinations are now offering a rich toolbox to study the proteome in many different dimensions. Given this background and the recent completion of in depth proteomes, clearly the time is right to apply proteomics in a more translational context to patient derived primary cells, organoids, xenograft models and indeed to the clinic. Such activities are well underway and we will focus on several distinct areas in this conference. MS based proteomics, in particular interaction proteomics in combination with chemical and structural proteomics, is making crucial contributions to drug development and deeper molecular understanding of disease mechanisms. The analysis of post-translational modifications has become orders of magnitude more comprehensive, quantitative and accessible, now enabling in-vivo and time-resolved studied of a large range of signaling processes. In combination with genome engineering, this opens up entirely new perspectives in precision investigation of deregulated signaling processes in models of oncology, immunology or metabolic diseases. Finally, proteomic profiling of body fluids has matured to a degree that it enables informative ‘phenotyping’ of humans in health and disease, supporting ‘wellness’ and patient stratification/biomarker studies. Additional details will be posted as soon as they are available.